NDC00002-7199-09 — VINCRISTINE SULFATE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00002-7199-09: VINCRISTINE SULFATE INJECTION.

The VINCRISTINE SULFATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: SYRINGE, supplementary_features: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.000 MILLILITERS, active_medicament_medicinal_strength: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-227-1609, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00002-7199-09

NSN: 6505-01-227-1609
FSC: 6505 — Drugs and Biologicals
CAGE: 75602 — ELI LILLY AND COMPANY (USA)

SPECIFICATIONS

primary_container_type	SYRINGE
supplementary_features	ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
protective_storage_feature	ANTINEOPLASTIC DRUG
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	3
primary_container_content_quantity	2.000 MILLILITERS
active_medicament_medicinal_strength	1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
part_name_assigned_by_controlling_agency	VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S
NSN	6505-01-227-1609

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS

•

SUPPLEMENTARY FEATURES: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: SYRINGE

•

PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER

•

TOTAL PRIMARY CONTAINER QUANTITY: 3

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	2.000 MILLILITERS
SUPPLEMENTARY FEATURES	ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	SYRINGE
PROTECTIVE STORAGE FEATURE	ANTINEOPLASTIC DRUG
PART NAME ASSIGNED BY CONTROLLING AGENCY	VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S
ACTIVE MEDICAMENT MEDICINAL STRENGTH	1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY	3

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

ONCOVINReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC00002-7199-09?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00002-7199-09?

NDC00002-7199-09 is a VINCRISTINE SULFATE INJECTION.

What parts can replace NDC00002-7199-09?

There is 1 known substitute for NDC00002-7199-09: ONCOVIN. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00002-7199-09?

NDC00002-7199-09 is cataloged in the U.S. Government catalog under NSN 6505-01-227-1609. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00002-7199-09 — VINCRISTINE SULFATE INJECTION

Request a Quote — NDC00002-7199-09